Tag: percutaneous mechanical circulatory support devices market forecast

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Percutaneous Mechanical Circulatory Support Devices Market During The 2026–2030 Period?

The percutaneous mechanical circulatory support devices market has witnessed robust growth in recent years. It is anticipated to increase from $2.46 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.7%. Historically, this expansion has been driven by factors such as a rising incidence of cardiovascular diseases, an increase in cardiogenic shock cases, the adoption of minimally invasive procedures, the expansion of ICU care facilities, and an aging population.

The percutaneous mechanical circulatory support devices market is anticipated to experience robust expansion over the coming years. This market is projected to reach $3.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. Key factors contributing to this growth during the forecast period include AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, the rising demand for temporary heart support, and advancements in pump technologies. Significant trends identified for the upcoming period encompass minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and designs focused on enhanced patient safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

Which Drivers Are Advancing The Percutaneous Mechanical Circulatory Support Devices Market Growth?

The rising occurrence of cardiovascular diseases is anticipated to fuel the expansion of the percutaneous mechanical circulatory support devices market moving forward. Cardiovascular diseases (CVDs) represent a collection of ailments affecting the heart and blood vessels, covering conditions like coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The escalating incidence of these diseases can be attributed to elements such as an aging population, detrimental lifestyle choices, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are utilized in the context of cardiovascular diseases to enhance cardiac function, lessen strain on the heart, and assist recovery during critical heart conditions. For example, in October 2024, statistics from the Centers for Disease Control and Prevention, a US-based public health institute, revealed that in 2023, around 1 out of every 6 deaths from cardiovascular diseases impacted adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, which represented 1 in every 3 deaths. Thus, the growing prevalence of cardiovascular diseases is driving the development of the percutaneous mechanical circulatory support (MCS) devices market.

What Segment Types Are Included In The Percutaneous Mechanical Circulatory Support Devices Market Analysis?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Which Trends Are Contributing To Changes In The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies in the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a type of percutaneous mechanical circulatory support (MCS) device designed to assist heart function by enhancing blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, announced the successful first-in-human use of its Aortix pump. This innovative device is intended to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump improves renal perfusion while reducing the heart’s workload during surgery. It achieves this by boosting both renal and systemic perfusion and simultaneously decreasing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).

Which Key Players Are Active In The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Access The Complete Percutaneous Mechanical Circulatory Support Devices Market Report:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Which Region Stands As The Largest Contributor To The Percutaneous Mechanical Circulatory Support Devices Market?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Percutaneous Mechanical Circulatory Support Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Percutaneous Mechanical Circulatory Support Devices Market Between 2026 And 2030?

The percutaneous mechanical circulatory support devices market has experienced robust growth in its size over recent years. It is projected to expand from $2.46 billion in 2025 to $2.7 billion in 2026, showing a compound annual growth rate (CAGR) of 9.7%. The market’s past growth is attributable to an escalating burden of cardiovascular disease, a rise in cardiogenic shock cases, the adoption of minimally invasive procedures, the expansion of ICU care, and an aging population.

The percutaneous mechanical circulatory support devices market size is anticipated to experience robust expansion in the coming years. It is forecast to reach $3.87 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.4%. The growth during this forecast period can be attributed to elements such as AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the broadening scope of cath lab procedures, the demand for temporary heart support, and advanced pump technologies. Key trends identified for the forecast period include minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and enhanced patient safety designs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

What Major Factors Are Driving The Percutaneous Mechanical Circulatory Support Devices Market Forward?

The rising occurrence of cardiovascular diseases is projected to drive expansion within the percutaneous mechanical circulatory support devices market in the future. Cardiovascular diseases, abbreviated as CVDs, encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, myocardial infarctions, heart failure, cerebrovascular accidents, and hypertension. This growing prevalence of cardiovascular diseases stems from factors like an aging demographic, poor lifestyle decisions, excessive weight, high blood pressure, and inherited predispositions. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance heart function, alleviate stress on the heart, and aid recovery during severe cardiac states. A notable example is provided by the Centers for Disease Control and Prevention, a US-based public health institute, which reported in October 2024 that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old. Furthermore, a grand total of 919,032 people succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.

Which Segment Types Are Examined In The Percutaneous Mechanical Circulatory Support Devices Market Segment Study?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Which Trends Are Impacting The Progress Of The Percutaneous Mechanical Circulatory Support Devices Market?

Leading companies operating within the percutaneous mechanical circulatory support devices market are prioritizing the development of technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a form of percutaneous mechanical circulatory support (MCS) device engineered to aid heart function by boosting blood flow from the left ventricle to the aorta. For example, in February 2023, Procyrion, Inc., a US-based medical device firm, announced the successful first-in-human application of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in individuals undergoing cardiac surgery. Introduced via a catheter in the descending thoracic aorta, the Aortix pump enhances renal perfusion while simultaneously reducing the heart’s workload during surgery. It accomplishes this by improving both renal and systemic perfusion while concurrently lessening the strain on the heart, rendering it particularly beneficial for patients with compromised left ventricular function and renal impairment. With the capacity to deliver up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary deployment during procedures like percutaneous coronary interventions (PCI).

Which Players Are Part Of The Competitive Landscape Of The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Get The Full Percutaneous Mechanical Circulatory Support Devices Market Report:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Where Is The Percutaneous Mechanical Circulatory Support Devices Market Primarily Concentrated By Region?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Percutaneous Mechanical Circulatory Support Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Percutaneous Mechanical Circulatory Support Devices Market Between 2026 And 2030?

The percutaneous mechanical circulatory support devices market has experienced robust growth in its size over recent years. It is projected to expand from $2.46 billion in 2025 to $2.7 billion in 2026, showing a compound annual growth rate (CAGR) of 9.7%. The market’s past growth is attributable to an escalating burden of cardiovascular disease, a rise in cardiogenic shock cases, the adoption of minimally invasive procedures, the expansion of ICU care, and an aging population.

The percutaneous mechanical circulatory support devices market size is anticipated to experience robust expansion in the coming years. It is forecast to reach $3.87 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.4%. The growth during this forecast period can be attributed to elements such as AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the broadening scope of cath lab procedures, the demand for temporary heart support, and advanced pump technologies. Key trends identified for the forecast period include minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and enhanced patient safety designs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

What Major Factors Are Driving The Percutaneous Mechanical Circulatory Support Devices Market Forward?

The rising occurrence of cardiovascular diseases is projected to drive expansion within the percutaneous mechanical circulatory support devices market in the future. Cardiovascular diseases, abbreviated as CVDs, encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, myocardial infarctions, heart failure, cerebrovascular accidents, and hypertension. This growing prevalence of cardiovascular diseases stems from factors like an aging demographic, poor lifestyle decisions, excessive weight, high blood pressure, and inherited predispositions. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance heart function, alleviate stress on the heart, and aid recovery during severe cardiac states. A notable example is provided by the Centers for Disease Control and Prevention, a US-based public health institute, which reported in October 2024 that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old. Furthermore, a grand total of 919,032 people succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.

Which Segment Types Are Examined In The Percutaneous Mechanical Circulatory Support Devices Market Segment Study?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Which Trends Are Impacting The Progress Of The Percutaneous Mechanical Circulatory Support Devices Market?

Leading companies operating within the percutaneous mechanical circulatory support devices market are prioritizing the development of technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a form of percutaneous mechanical circulatory support (MCS) device engineered to aid heart function by boosting blood flow from the left ventricle to the aorta. For example, in February 2023, Procyrion, Inc., a US-based medical device firm, announced the successful first-in-human application of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in individuals undergoing cardiac surgery. Introduced via a catheter in the descending thoracic aorta, the Aortix pump enhances renal perfusion while simultaneously reducing the heart’s workload during surgery. It accomplishes this by improving both renal and systemic perfusion while concurrently lessening the strain on the heart, rendering it particularly beneficial for patients with compromised left ventricular function and renal impairment. With the capacity to deliver up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary deployment during procedures like percutaneous coronary interventions (PCI).

Which Players Are Part Of The Competitive Landscape Of The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Get The Full Percutaneous Mechanical Circulatory Support Devices Market Report:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Where Is The Percutaneous Mechanical Circulatory Support Devices Market Primarily Concentrated By Region?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Percutaneous Mechanical Circulatory Support Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Percutaneous Mechanical Circulatory Support Devices Market Evolve From 2026 To 2030?

The percutaneous mechanical circulatory support devices market size has shown robust growth in recent years. Its value is anticipated to rise from $2.46 billion in 2025 to $2.7 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.7%. This expansion during the historic period can be ascribed to a climbing burden of cardiovascular disease, an increase in cardiogenic shock cases, the uptake of minimally invasive procedures, broader ICU care, and an aging population.

The percutaneous mechanical circulatory support devices market size is projected to undergo significant expansion in the upcoming years, with its value set to reach $3.87 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This growth during the forecast period is propelled by factors such as AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, the escalating demand for temporary heart support, and advanced pump technologies. Noteworthy trends anticipated in the forecast period include advancements in minimally invasive cardiac support, short-term hemodynamic assistance solutions, devices for high-risk PCI support, rapid deployment cardiac systems, and designs focused on enhanced patient safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Major Drivers Are Influencing Demand In The Percutaneous Mechanical Circulatory Support Devices Market?

The escalating occurrence of cardiovascular diseases is anticipated to drive expansion in the percutaneous mechanical circulatory support devices market. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. This rise in CVD incidence stems from factors like an aging demographic, unhealthy lifestyle decisions, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are employed for cardiovascular diseases to enhance cardiac function, alleviate heart strain, and aid recovery during severe heart conditions. As an illustration, the Centers for Disease Control and Prevention, a US-based public health institute, reported in October 2024 that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old, with a total of 919,032 people dying from cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the growing occurrence of cardiovascular diseases is fueling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.

Which Segment Areas Are Covered In The Percutaneous Mechanical Circulatory Support Devices Market Analysis?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

What Key Developments And Trends Are Impacting The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device serves as a type of percutaneous mechanical circulatory support (MCS) device engineered to aid heart function by augmenting blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, announced the successful first-in-human use of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump improves renal perfusion while decreasing the heart’s workload during surgery, achieving this by enhancing both renal and systemic perfusion while simultaneously reducing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).

Which Global Companies Are Actively Competing In The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Read the full percutaneous mechanical circulatory support devices market report here:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Percutaneous Mechanical Circulatory Support Devices Market?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Percutaneous Mechanical Circulatory Support Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Percutaneous Mechanical Circulatory Support Devices Market expected to reach by 2030?

The percutaneous mechanical circulatory support devices market has experienced robust expansion in recent years. Its value is projected to climb from $2.46 billion in 2025 to $2.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This historical growth has been driven by an increasing burden of cardiovascular diseases, a rise in cardiogenic shock incidents, the widespread adoption of minimally invasive procedures, the expansion of intensive care unit (ICU) services, and an aging global population.

The percutaneous mechanical circulatory support devices market is anticipated to experience substantial expansion over the coming years. This market is projected to reach a valuation of $3.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. Several factors are contributing to this growth during the forecast period, including AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, a rising demand for temporary heart support, and advancements in pump technologies. Furthermore, significant trends expected during this period involve minimally invasive cardiac support, short-term hemodynamic assistance, support devices for high-risk PCI procedures, rapid deployment cardiac systems, and designs focused on enhanced patient safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Drivers Are Driving Adoption Within The Percutaneous Mechanical Circulatory Support Devices Market?

The rising occurrence of cardiovascular diseases is anticipated to fuel the expansion of the percutaneous mechanical circulatory support devices market in the foreseeable future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. This growing prevalence of cardiovascular diseases stems from factors like an aging population, poor lifestyle habits, obesity, high blood pressure, and genetic susceptibility. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance heart function, lessen cardiac strain, and aid recuperation during severe heart ailments. For example, data from October 2024, provided by the Centers for Disease Control and Prevention, a US-based public health institute, revealed that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old, with a total of 919,032 people succumbing to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the rising occurrence of cardiovascular diseases is propelling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.

How Is The Percutaneous Mechanical Circulatory Support Devices Market Organized Into Various Segments?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

What Trends Are Reshaping The Dynamics Of The Percutaneous Mechanical Circulatory Support Devices Market?

Leading companies within the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a category of percutaneous mechanical circulatory support (MCS) device specifically engineered to aid heart function by increasing blood flow from the left ventricle into the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device firm, announced the successful initial human use of its Aortix pump. This innovative device aims to prevent acute kidney injury (AKI) in individuals undergoing cardiac surgery. Delivered through a catheter in the descending thoracic aorta, the Aortix pump enhances renal perfusion while simultaneously reducing the heart’s workload during the surgical procedure. It achieves this by improving both renal and systemic perfusion while decreasing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of providing up to 5.0 liters of flow per minute, the Aortix pump is designed for temporary application during procedures like percutaneous coronary interventions (PCI).

Who Are The Top-Performing Companies In The Percutaneous Mechanical Circulatory Support Devices Market In Recent Years?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

How Does The Percutaneous Mechanical Circulatory Support Devices Market Perform Across Major Global Regions?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Percutaneous Mechanical Circulatory Support Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Percutaneous Mechanical Circulatory Support Devices Market From 2025 To 2034?

The market encompassing percutaneous mechanical circulatory support devices has experienced robust expansion lately, projected to ascend from a value of $2.26 billion in the year 2024 to $2.46 billion by 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This historical upward trajectory is primarily a consequence of the rising frequency of cardiovascular ailments, an expanding elderly demographic, a greater number of heart attack occurrences, heightened public consciousness alongside proactive screening initiatives, and a surging requirement for cardiac assist pumping apparatuses.

Forecasting robust expansion, the market encompassing percutaneous mechanical circulatory support devices is projected to attain a valuation of $3.55 billion by 2029, reflecting a consistent compound annual growth rate of 9.5% throughout the projection timeframe. This upward trajectory is fueled by several factors, notably the increasing need for sustained mechanical cardiac assistance, escalating global healthcare spending, a growing prevalence of both diabetes and obesity, the greater necessity for cardiac transplant options, and the wider adoption of catheter-based medical interventions. Key developments shaping this market segment going forward involve progress in pump innovation, ongoing improvements in medical device technology, advancements in cardiac assistance methodologies, the evolution of less invasive medical techniques, and the ongoing creation of materials that are better tolerated by biological systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Are The Key Drivers Of Growth In The Percutaneous Mechanical Circulatory Support Devices Market?

Anticipated expansion in the market for percutaneous mechanical circulatory support devices is directly linked to the rising prevalence of affections of the heart and blood vessels, commonly known as cardiovascular diseases (CVDs), a category encompassing ailments like stroke, elevated blood pressure, heart failure, myocardial infarctions, and coronary artery disease. A confluence of elements contributes to this surge in CVD cases, notably demographic shifts toward an older population, suboptimal lifestyle habits, elevated rates of obesity and hypertension, alongside underlying genetic vulnerabilities. These percutaneous mechanical assist devices play a crucial role in managing CVD, serving to bolster heart performance, alleviate stress on the cardiac muscle, and foster recuperation during severe cardiac events; for example, data from the Australian Institute of Health and Welfare indicated that physician-confirmed fatalities attributed to coronary heart disease (CHD) climbed from 14,100 in 2021 to 14,900 across Australia in 2022, thereby underscoring how the growing burden of cardiovascular illness fuels the trajectory of the percutaneous MCS device sector.

What Are The Leading Segments Analyzed In The Percutaneous Mechanical Circulatory Support Devices Market?

The percutaneous mechanical circulatory support devicesmarket covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

What Long-Term Trends Will Shape The Future Growth Of The Percutaneous Mechanical Circulatory Support Devices Industry?

Leading firms within the arena of percutaneous mechanical circulatory support devices are channeling efforts toward innovating highly sophisticated apparatuses, notably intra-aortic axial-flow systems, with the dual aims of improving clinical results for patients and mitigating the perils associated with surgical interventions. This specific category of percutaneous mechanical circulatory support (MCS) equipment, known as an intra-aortic axial-flow device, functions by bolstering cardiac performance through the augmentation of blood movement directly from the left ventricle into the aorta. As an illustration, in the month of February in 2023, Procyrion, Inc., a medical technology corporation headquartered in the United States, shared news of the inaugural successful application in a human subject involving their Aortix pump. This novel mechanism has been engineered specifically to forestall acute kidney injury (AKI) in individuals undergoing heart operations. Through catheter delivery into the descending thoracic aorta, the Aortix pump serves to boost blood supply to the kidneys and lessen the effort expended by the heart throughout the surgical process. By simultaneously elevating perfusion to both the renal system and the broader circulatory network while concurrently lightening the cardiac burden, this technology presents significant benefits, particularly for those whose left ventricular function is already compromised or who suffer from kidney problems. The Aortix pump, which holds the capacity to move as much as 5.0 liters of fluid every minute, is slated for short-term application during various procedures, including percutaneous coronary interventions (PCI).

Who Are The Key Multinational Companies Dominating The Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

What Are The Regional Market Dynamics Impacting The Percutaneous Mechanical Circulatory Support Devices Industry?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Percutaneous Mechanical Circulatory Support Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2025, By The Business Research Company

Mechanical Power Transmission Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mechanical-power-transmission-equipment-global-market-report

Mechanical Ventilator Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mechanical-ventilator-global-market-report

Microelectromechanical Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/microelectromechanical-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Percutaneous Mechanical Circulatory Support Devices Market’s Growth Trajectory From 2025 To 2034?

Over recent years, the market size for percutaneous mechanical circulatory support devices has seen significant growth. Expansion is projected to continue, with an increase from $2.26 billion in 2024 to $2.46 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this historic period of growth include a rise in cardiovascular disease cases, a growing older population, an increase in heart attack occurrences, heightened awareness and screening programs, and a heightened demand for heart pump devices.

The market for percutaneous mechanical circulatory support devices is predicted to witness significant growth in the upcoming years and is estimated to reach $3.55 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.5%. This growth over the forecast period can be associated with an increase in requirements for long-term mechanical circulatory support, a surge in health care spending, a growing number of diabetics and obese individuals, a rising demand for heart transplants, and increased acceptance of percutaneous procedures. Key trends anticipated during this forecast period consist of developments in pump technology, progress in medical technology, cardiac support technologies, minimally invasive medical technologies, and the production of biocompatible materials.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What are the Fundamental Drivers and Innovations Shaping the Percutaneous Mechanical Circulatory Support Devices Market?

The escalating prevalence of cardiovascular ailments is poised to stimulate the expansion of the percutaneous mechanical circulatory support devices market. Cardiovascular diseases (CVDs), which encompass a range of disorders impacting the heart and blood vessels such as coronary artery disease, heart attacks, heart failure, stroke, and hypertension, are on the rise due to a plethora of factors. This includes an aging demographic, unhealthy lifestyle habits, obesity, high blood pressure, and a genetic susceptibility. Percutaneous mechanical circulatory support devices come into play in cardiovascular disease scenarios to enhance cardiac performance, alleviate heart strain, and foster recovery during severe heart complications. For example, data from the Australian Institute of Health and Welfare in December 2023, an Australian government body, showed an increase in doctor-certified deaths from coronary heart disease (CHD) to 14,100 in 2021 and a surge to 14,900 in 2022. Consequently, this rising prevalence of cardiovascular diseases is fueling the growth of the percutaneous mechanical circulatory support (MCS) devices market.

How Is the Percutaneous Mechanical Circulatory Support Devices Market Segmented?

The percutaneous mechanical circulatory support devicesmarket covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Which Regions Are Driving the Next Phase of the Percutaneous Mechanical Circulatory Support Devices Market Growth?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Percutaneous Mechanical Circulatory Support Devices Market?

Leading firms in the percutaneous mechanical circulatory support devices market are concentrating on the creation of cutting-edge solutions like intra-aortic axial-flow devices to heighten patient results and cut down on surgical risks. Intra-aortic axial-flow devices are a kind of percutaneous mechanical circulatory support (MCS) tool, developed to boost heart performance by augmenting the blood transmission from the left ventricle to the aorta. For instance, in February 2023, US-based medical device firm, Procyrion, Inc, unveiled the successful maiden human application of their Aortix pump. This trailblazing gadget is engineered to ward off acute kidney injury (AKI) in patients getting cardiac surgery. Positioned through a catheter in the descending thoracic aorta, the Aortix pump uplifts kidney perfusion while minimizing the heart’s effort during surgery. It accomplishes this by simultaneously amplifying renal and systemic perfusion, and lessening stress on the heart, making it particularly useful for individuals with weakened left ventricular function and kidney problems. The Aortix pump, which is capable of administering up to 5.0 liters of flow per minute, is planned for transitory use during operations like percutaneous coronary interventions (PCI).

View the full report here:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

How Is the Percutaneous Mechanical Circulatory Support Devices Market Defined and What Are Its Core Parameters?

Percutaneous mechanical circulatory support (pMCS) devices are minimally invasive systems used to temporarily assist or completely replace the pumping function of the heart. These devices are inserted through a catheter into blood vessels, typically via the femoral artery, and positioned in the heart to provide mechanical support during acute heart failure, cardiogenic shock, or high-risk cardiac interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Percutaneous Mechanical Circulatory Support Devices Market?

The market for percutaneous mechanical circulatory support devices has seen rapid expansion in the past few years. The market is forecasted to increase from $2.26 billion in 2024 to $2.48 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.0%. Several factors have contributed to the historical growth of this market, including a rise in cardiovascular disease cases, a growing elderly population, an increase in heart attack occurrences, improved awareness and screening initiatives, and heightened demand for heart pump apparatus.

What Growth Rate Is Forecasted for the Percutaneous Mechanical Circulatory Support Devices Market by 2029?

In the coming years, the percutaneous mechanical circulatory support devices market size is slated for robust growth, anticipated to reach a value of $3.60 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.7%. This projected growth during the forecast period can be ascribed to the escalating demand for long-term mechanical circulatory support, an increase in healthcare expenditure, the rising prevalence of diabetes and obesity, an upsurge in heart transplants, and heightened acceptance of percutaneous procedures. The major directional changes anticipated on this trajectory entail advancements in pump technology and medical technology, inventions in cardiac support technologies, the emergence of minimally invasive medical technologies, and the development of biocompatible materials.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

Which Key Companies Are Shaping the Future of the Percutaneous Mechanical Circulatory Support Devices Market?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Which Factors Are Driving Demand in the Percutaneous Mechanical Circulatory Support Devices Industry?

The rising cases of cardiovascular illnesses are projected to fuel the expansion of the percutaneous mechanical circulatory support devices market in the future. Cardiovascular diseases, or CVDs, encompass a spectrum of disorders that impact the heart and blood vessels – these include, but are not limited to, coronary artery disease, heart attacks, heart failure, stroke, and hypertension. The rise in cardiovascular disease can be tied to demographic aging, poor lifestyle choices, obesity, elevated blood pressure, and a genetic inclination towards such diseases. Percutaneous mechanical circulatory support devices serve a vital function in the treatment of cardiovascular diseases by enhancing cardiac functionality, lessening the burden on the heart, and aiding healing in severe heart conditions. For example, data from the Australian Institute of Health and Welfare – a government agency based in Australia – from December 2023 revealed that doctor-certified fatalities as result of coronary heart disease increased from 14,100 in 2021 to 14,900 in 2022. Consequently, the surge in cardiovascular illnesses is propelling the advancement of the percutaneous mechanical circulatory support (MCS) devices market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

How Is the Percutaneous Mechanical Circulatory Support Devices Market Segmented by Several Divisions?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

What are the Emerging Market Trends Driving the Growth of the Percutaneous Mechanical Circulatory Support Devices Industry?

Leading businesses in the percutaneous mechanical circulatory support devices market are concentrating their efforts on creating modern and technologically advanced solutions such as intra-aortic axial-flow devices. These solutions aim to improve patient results while reducing the risks associated with surgery. An intra-aortic axial-flow device, a form of percutaneous mechanical circulatory support (MCS) device, is created to bolster heart function by enhancing the blood flow from the left ventricle to the aorta. For example, Procyrion, Inc., a medical device firm from the United States, unveiled its Aortix pump in February 2023, achieving its first successful application in a human. The Aortix pump, designed to prevent acute kidney damage in cardiac surgery patients, is introduced through a catheter into the descending thoracic aorta and improves renal perfusion while easing the heart’s burden during surgery. The pump boosts both renal and systemic perfusion and simultaneously reduces cardiac strain, yielding significant benefits for patients with comprised left ventricular function and renal deficiencies. The Aortix pump can deliver up to 5.0 liters of flow per minute and is designed for temporary use in procedures like percutaneous coronary interventions (PCI).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Which Regions Are Driving Growth in the Percutaneous Mechanical Circulatory Support Devices Market?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921

This Report Delivers Insight On:

1. How big is the percutaneous mechanical circulatory support devices market, and how is it changing globally?

2. Who are the major companies in the percutaneous mechanical circulatory support devices market, and how are they performing?

3. What are the key opportunities and risks in the percutaneous mechanical circulatory support devices market right now?

4. Which products or customer segments are growing the most in the percutaneous mechanical circulatory support devices market?

5. What factors are helping or slowing down the growth of the percutaneous mechanical circulatory support devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What is the Projected CAGR for the Percutaneous Mechanical Circulatory Support Devices Market Size from 2025 to 2034?

The market for percutaneous mechanical circulatory support devices has seen a significant expansion in recent years. The market, which was worth $2.26 billion in 2024, is expected to rise to $2.48 billion in 2025, registering a compound annual growth rate (CAGR) of 10.0%. Factors contributing to growth during the historic period include a rise in cardiovascular diseases, an ageing population, greater incidences of heart attacks, enhanced awareness and screening initiatives, and higher demand for heart pump devices.

The market size for percutaneous mechanical circulatory support devices is forecasted to experience substantial growth in the coming years. The market is anticipated to reach a value of $3.60 billion by 2029, increasing at a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this expected growth during the forecast period include an increased need for long-term mechanical circulatory support, a rise in healthcare spending, growing numbers of individuals with diabetes and obesity, an increased demand for heart transplants, and wider acceptance of percutaneous procedures. Other influential trends during the forecast period comprise advancements in pump and cardiac support technologies, progress in minimally invasive medical technologies, and creation of biocompatible material.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Percutaneous Mechanical Circulatory Support Devices Market?

An upsurge in cardiovascular diseases is predicted to boost the growth trajectory of the percutaneous mechanical circulatory support devices market. These diseases collectively involve disorders impacting the heart and blood vessels, including coronary artery disease, heart failure, heart attacks, stroke, and elevated blood pressure. The escalating incidence rates of cardiovascular conditions can be linked to an aging demographic, unhealthy lifestyle habits, obesity, hypertension, and genetic susceptibility. Percutaneous mechanical circulatory support devices are employed in treating cardiovascular diseases to enhance cardiac functionality, alleviate heart strain, and help facilitate recovery in severe heart conditions. As an example, in December 2023, the Australian Institute of Health and Welfare, a governmental agency in Australia, reported an increase in doctor-certified deaths due to coronary heart disease (CHD) to 14,100 in 2021 and subsequently to 14,900 in 2022. As such, the mounting incidence of cardiovascular diseases is catalyzing the growth of the percutaneous mechanical circulatory support (MCS) devices market.

Which Key Market Segments Comprise the Percutaneous Mechanical Circulatory Support Devices Market and Drive Its Revenue Growth?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Which Areas Are Leading Regions in the Percutaneous Mechanical Circulatory Support Devices Market Expansion Across the Globe?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Percutaneous Mechanical Circulatory Support Devices Industry Evolution?

Leading firms in the percutaneous mechanical circulatory support devices market are striving to create groundbreaking solutions such as intra-aortic axial-flow devices to improve patient results and lessen surgical hazards. The intra-aortic axial-flow device, a form of percutaneous mechanical circulatory support device, is crafted to support the cardiovascular function by boosting the blood flow from the left ventricle to the aorta. For example, in February 2023, US medical device company Procyrion, Inc. revealed the successful inaugural human usage of their Aortix pump. This novel device aims to avert acute kidney injury in patients during cardiac surgery. Deployed via a catheter into the descending thoracic aorta, the Aortix pump elevates renal perfusion and reduces the cardiac stress during surgery. It manages to do so by simultaneously improving renal and systemic perfusion and decreasing heart strain, marking it as highly beneficial for patients with weak left ventricular function and kidney impairment. The Aortix pump, capable of pumping up to 5.0 liters per minute, is designed for temporary use in procedures like percutaneous coronary interventions (PCI).

View the full report here:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

How Is the Percutaneous Mechanical Circulatory Support Devices Market Conceptually Defined?

Percutaneous mechanical circulatory support (pMCS) devices are minimally invasive systems used to temporarily assist or completely replace the pumping function of the heart. These devices are inserted through a catheter into blood vessels, typically via the femoral artery, and positioned in the heart to provide mechanical support during acute heart failure, cardiogenic shock, or high-risk cardiac interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model